Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...

The Company is currently developing a long-term implantable continuous blood glucose monitoring system for people living with diabetes. Glucotrack’s CBGM is a long-term, implantable system that ...

usage and removal of the CBGM sensor lead. While neither the study nor prototype system was designed to evaluate sensor accuracy, the system performed as expected with similar accuracy results as ...

Glucotrack is focused on innovating diabetes care technologies, including a long-term implantable CBGM system that measures blood glucose with minimal calibration needs. For further details ...

Glucotrack's CBGM system represents the company's focus on the design, development, and commercialization of innovative technologies for diabetes care. However, the press release also contains ...

Williams, with nearly a quarter-century of experience in regulatory affairs and quality assurance for complex medical devices, is expected to play a critical role in advancing the company's continuous ...